Skip to content

Lesser Poland Cracovian Heart Failure Registry

Lesser Poland Cracovian Heart Failure Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05746923
Acronym
LECRA-HF
Enrollment
2500
Registered
2023-02-28
Start date
2023-02-15
Completion date
2026-12-31
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Heart Failure Acute

Keywords

heart failure, acute heart failure, decompensation, revascularization, long-term prognosis

Brief summary

The goal of Lesser Poland Cracovian Heart Failure Registry (LECRA-HF) is to expand the knowledge about acute heart failure (AHF) and its long-term prognosis. The main questions are: * assessment of long-term prognosis of AHF and its determinants * determination of the optimal AHF treatment methods * assessment of indications for invasive coronary arteries diagnostics and revascularization and their long-term effects * analysis of the particular HF subtypes (HFimpEF, HFpEF, HFsnEF, HFrEF, HFmrEF)

Detailed description

LECRA-HF is a registry of patients with acute heart failure (AHF) hospitalized in the Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow, Jagiellonian University Medical College. So far, a small population of patients has been included in similar registries conducted in the Polish population. This did not allow to draw reliable conclusions about this diverse group of patients. As part of the LECRA-HF registry, a comprehensive analysis of the clinical characteristics of patients is planned, taking into account their medical history, anthropometric measurements, results of electrocardiographic, imaging and laboratory tests, as well as the treatment used during the index hospitalization and after discharge. Their long-term prognosis will also be analyzed. LECRA-HF is a continuous registry, updated annually until 2026. The data collected in the LECRA-HF will be used to distinguish and describe relatively new subtypes of HF (HFimpEF, HFsnEF) as well as to properly characterize that difficult and very diverse population with a serious long-term prognosis.

Interventions

None listed

Sponsors

Jagiellonian University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hospitalization due to acute heart failure * \> 18 years of age

Exclusion criteria

* inability to give informed consent to participate in the registry

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortality2 yearsMortality due to all causes

Secondary

MeasureTime frameDescription
Cardiovascular mortality2 yearsMortality due to CV causes
HF rehospitalizations2 yearsRehospitalizations related to HF decompensation

Other

MeasureTime frameDescription
LVEF increase >10% in the follow-up echocardiography2 yearsIn accordance with HFimpEF definition

Countries

Poland

Contacts

Primary ContactKonrad Stępień, MD
konrad.stepien@uj.edu.pl12 614 22 18
Backup ContactKarol Nowak, MD
karol.nowak@student.uj.edu.pl12 614 22 18

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026